⚠️ Research use only Not for human consumption. FDA unapproved. Consult a doctor. 18+ only.

Hilma Biocare Semaglutide 5 mg — Weight loss support

Semaglutide is a GLP-1 receptor agonist (similar to Ozempic/Wegovy) designed to promote weight loss and improve blood sugar control.

What it does

Semaglutide activates GLP-1 receptors to reduce appetite, increase satiety, slow gastric emptying, and improve glucose regulation—supporting sustainable weight loss.

How to use it

  • Dosing schedule: Start at 0.25 mg weekly, increase gradually every 4 weeks
  • Target dose: 0.5-2.4 mg weekly as tolerated
  • Administration: Subcutaneous injection once weekly

Important notes

Not for use in pregnancy or breastfeeding. Monitor for GI side effects. Consult with a healthcare professional before use.

Delivery region

Target outcome

Substance

Form factor

There are no reviews yet.

Be the first to review “Hilma Biocare Semaglutide pre-filled pen 5 mg”

Your email address will not be published. Required fields are marked *